US Stocks
/
Definium Therapeutics, Inc. Share Price

Definium Therapeutics, Inc. Share Price

NASDAQ: DFTX | Mid Cap
$34.17
-$0.89 (-2.54%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Definium Therapeutics, Inc. Stock Performance

Open
$34.62
Prev. Close
$35.06
Circuit Range
N/A
Day Range
$32.86 - $34.70
Year Range
$14.74 - $49.66
Volume
94,731
Average Traded
$33.98

Definium Therapeutics, Inc. Share Price Today

As of 9 October 2026, Definium Therapeutics, Inc.'s share price is $34.17. The stock opened at $34.62, compared to its previous close of $35.06. During today's trading session, Definium Therapeutics, Inc.'s share price traded between $32.86 and $34.70, with an average price of $33.78. Over the past 52 weeks, the stock has recorded a high of $49.66 and a low of $14.74. In terms of performance, Definium Therapeutics, Inc.'s share price has risen by 56.13% over the last six months and is up 102.55% on a year-on-year basis.

Definium Therapeutics, Inc. Share Price Chart

$32.86$34.70
L
Show Current Price
H

Definium Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.05B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.63
Revenue (TTM)
N/A
Return On Equity (TTM)
-38.51%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
N/A

Definium Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026
Revenue$0.00$0.00
Net Profit-$77.10-$158.99
Net Profit MarginN/AN/A
Income ChangeN/A-106.21%

About Definium Therapeutics, Inc.

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Definium Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$37.83
$34.28
-10.07%
Sep 2026
$39.86
$38.12
-12.97%
Aug 2026
$42.56
$43.80
+0.69%
Jul 2026
$47.08
$43.50
-7.45%
Jun 2026
$24.24
$47.00
+94.46%
May 2026
$22.05
$24.17
+10.44%
Apr 2026
$19.50
$21.89
+15.85%
Mar 2026
$16.89
$18.89
+8.13%
Feb 2026
$16.98
$17.47
+3.56%
Jan 2026
$15.00
$16.87
N/A

DFTX Share Price FAQs

What is Definium Therapeutics, Inc. share price today?

chevron-up
Definium Therapeutics, Inc. share price today is $34.17 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Definium Therapeutics, Inc. stock?

chevron-up
The 52 week high of Definium Therapeutics, Inc. stock is $49.66, while the 52 week low is $14.74 as of 9 Oct '26.

What is DFTX's market capitalisation today?

chevron-up
DFTX market capitalisation is $3.05B as of October 9, 2026, at 6:21 am IST.

What is DFTX's net income for the last quarter?

chevron-up
DFTX's net income for the last quarter is -158.99B USD.

What is the 5 year returns of DFTX?

chevron-up
The 5 year returns of DFTX is 102.55% as on 9 Oct '26.

What is the high & low stock price of DFTX today?

chevron-up
DFTX stock price hit a high of $34.70 and low of $32.86 as of 9 Oct '26.

Can I buy DFTX shares in India?

chevron-up
Yes. You can buy DFTX in India by opening an international trading account.